BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10109799)

  • 1. Projected cost savings associated with cefmetazole: a new cephamycin for the hospitalized patient.
    Crane VS
    Hosp Formul; 1991 Apr; 26(4):302-6, 309-10. PubMed ID: 10109799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulary evaluation of second-generation cephamycin derivatives using decision analysis.
    Barriere SL
    Am J Hosp Pharm; 1991 Oct; 48(10):2146-50. PubMed ID: 1781469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs.
    Abramowitz PW; Nold EG; Hatfield SM
    Am J Hosp Pharm; 1982 Jul; 39(7):1176-80. PubMed ID: 7114059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost savings realized from interchanging ceftizoxime for cefoxitin.
    Guastella C
    Am J Hosp Pharm; 1988 Nov; 45(11):2376-7. PubMed ID: 3228095
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic interchange of cefazolin with metronidazole for cefoxitin.
    Brown GR; Clarke AM
    Am J Hosp Pharm; 1992 Aug; 49(8):1946-50. PubMed ID: 1442838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary approach to cost reduction of C-section prophylaxis.
    Todd MW; Benrubi G
    Hosp Formul; 1990 Apr; 25(4):446-8, 450. PubMed ID: 10104235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy component of a hospital end-product cost-accounting system.
    Smith JE; Sheaffer SL; Meyer GE; Giorgilli F
    Am J Hosp Pharm; 1988 Apr; 45(4):835-43. PubMed ID: 3376968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefoxitin use review.
    Lazor-Bajcar JM
    Can J Hosp Pharm; 1990 Oct; 43(5):221-5, xxxii. PubMed ID: 10107924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining drug dispensing costs for use in cost-accounting systems.
    Thielke TS; Charlson JT; Heckethorn D
    Am J Hosp Pharm; 1988 Apr; 45(4):844-7. PubMed ID: 3376969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination.
    Ko H; Cathcart KS; Griffith DL; Peters GR; Adams WJ
    Antimicrob Agents Chemother; 1989 Mar; 33(3):356-61. PubMed ID: 2729930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative intraoperative concentrations of two cephalosporins with activity against anaerobic bacteria.
    DiPiro JT; Connors JE; Bowden TA; Stanfield JA; Lampert BM; Stewart JT
    J Antimicrob Chemother; 1989 Apr; 23 Suppl D():89-95. PubMed ID: 2722728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing a fee for handling investigational drug studies.
    Ngu BQ; Schneider PJ; Kilarski DJ
    Am J Hosp Pharm; 1982 Aug; 39(8):1308-10. PubMed ID: 7124750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of mixing clindamycin and aminoglycosides.
    Abel SR; Olson SM
    Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles and methods of managerial cost-accounting systems.
    Suver JD; Cooper JC
    Am J Hosp Pharm; 1988 Jan; 45(1):146-52. PubMed ID: 3348229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost comparison of two systems for intermittent intravenous administration of small-volume injections.
    Reilly RT; Strand LM; Bair JN
    Am J Hosp Pharm; 1985 Feb; 42(2):323-8. PubMed ID: 3976678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC; Sutton JD; Henderson GT
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost effective approach to surgical antibiotic prophylaxis.
    Pavan MM; Malyuk DL
    Can J Hosp Pharm; 1992 Aug; 45(4):151-6. PubMed ID: 10123058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effective implementation of clinical pharmacy services in an ambulatory care clinic.
    Jones RA; Lopez LM; Beall DG
    Hosp Pharm; 1991 Sep; 26(9):778-82. PubMed ID: 10114011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.